Bristol Myers Squibb Co. closed 2.19% below its 52-week high of $62.89, which the company reached on March 2nd.
Zacks Investment Research on MSN
Bristol Myers Squibb (BMY) rises as market takes a dip: Key facts
In the latest trading session, Bristol Myers Squibb (BMY) closed at $61.40, marking a +1.05% move from the previous day. The stock outpaced the S&P 500's daily loss of 1.21%. Elsewhere, the Dow lost 0 ...
The drugmaker will deploy NVIDIA's Vera Rubin systems, giving it what it calls the most powerful AI computing infrastructure ...
Bristol Myers Squibb (NYSE:BMY) is rolling out new AI infrastructure built on NVIDIA's latest architecture to support drug ...
Bristol Myers Squibb operates as a pure-play biopharmaceutical company focusing on serious diseases. The company develops and sells medicines in the healthcare stocks sector across oncology, ...
Fears about a looming patent cliff have dragged on the shares.
TORONTO (AP) — There are 70-year-olds who want to be like June Squibb when they grow up. Squibb, 95, wasn't the lead of a movie until she was 94. Now, a year after she turned action star in "Thelma," ...
Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the ...
Add Yahoo as a preferred source to see more of our stories on Google. June Squibb is on a roll. "(It's) her first feature directing," Squibb tells TODAY.com in a sit-down interview. A veteran of the ...
Christmas always has a special place for June Squibb. One of her first gigs as a struggling actress was as Santa Claus’ helper in a department store. You gotta start somewhere, so why not with Santa?
This article was featured in One Great Story, New York’s reading recommendation newsletter. Sign up here to get it nightly. June Squibb, 94, is driving me around the parking lot of her Sherman Oaks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results